Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Researchers made a cell line that grows quickly and can help with hair growth research.

The substance from human hair root cells can help maintain hair growth and make skin cells more capable of growing hair.

Fetal scalp cells have more regenerative genes than adult cells, and decellularized muscle matrix is better for muscle repair than commercial alternatives.

Baby and adult skin cells are different, with baby cells having more active pathways that could help grow new hair follicles.

The upper dermal sheath can regenerate hair in rats.

Stem cells from umbilical cords can help regrow hair in mice with hair loss.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Square-shaped hair loss can occur after treating a brain aneurysm due to localized radiation exposure.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Glycine soja extract stimulates hair growth and could help treat hair loss.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

BMPs are important for hair growth and can counteract the negative effects of androgens on hair follicle stem cells.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Wnt proteins from certain skin cells are crucial for normal hair growth and renewal.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Human hair cells can be used to grow new hair on rat ears, suggesting a possible treatment for hair loss.

The microenvironment, especially mechanical forces, plays a crucial role in hair growth and could lead to new treatments for hair loss.

Transplanted hair follicles show significant changes after FUE, needing more research.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.